Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Strides Declines to Comment on Report of Pills Unit Sale

Sept. 21 (Bloomberg) -- Strides Arcolab Ltd., an Indian drugmaker, declined to comment on a report that the company may sell its unit that makes generic tablets and capsules.

“We cannot offer any comment,” Chief Financial Officer T.S. Rangan said in an interview today, adding that the company will scale up its speciality injections business. “Obviously when you have to build an injectible business, you have to defocus” on other businesses, Rangan said.

The shares rose as much as 12.4 percent and changed hands at 335.45 rupees, up 10.7 percent, at 1:11 p.m. local time.

To contact the reporter on this story: Adi Narayan in Mumbai at anarayan8@bloomberg.net

To contact the editor responsible for this story: Pradeep Kurup at pkurup3@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.